Product
Zika Virus Purified Inactivated Vaccine (ZPIV)
1 clinical trial
1 indication
Indication
Zika virusClinical trial
A Phase 1, First-in-Human, Double-blinded, Randomized, Placebo-controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of an Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Healthy Flavivirus-Naïve and Flavivirus-Primed SubjectsStatus: Completed, Estimated PCD: 2018-10-30